The implications of these findings extend beyond simple correlation, indicating that PSMD14 may affect the tumor microenvironment and immune responses, thereby enhancing the understanding of the pathogenesis of LUAD while opening new pathways for therapeutic interventions. The gene discussed is PSMD14; the disease is neoplasm.